U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 543 records

Showing results for "anticoagulant prophylaxis".

  1. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/836840/psn-pdf
    April 22, 2021 - to patients and how to administer VTE prophylaxis. … Understand barriers to VTE prophylaxis at the institution. … clinical decision support tool for prophylaxis for venous thromboembolism in trauma. … Venous Thromboembolism Prophylaxis (eCQM). … clinical decision support tool for prophylaxis for venous thromboembolism in trauma.

  2. Hidden Heparins: HIT Happens | PSNet

    psnet.ahrq.gov/web-mm/hidden-heparins-hit-happens
    March 27, 2024 - warfarin is introduced in a patient with HIT and typically begins within days of starting the oral anticoagulant … Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysis. … Description Indication Dosing Comment Argatroban Synthetic direct thrombin inhibitor Prophylaxis … Related Resources WebM&M Cases Direct Oral Anticoagulants … See More About The Topic Hospitals Physicians Risk Managers Medicine Anticoagulants

  3. Comanagement: Who's in Charge? | PSNet

    psnet.ahrq.gov/web-mm/comanagement-whos-charge
    July 01, 2011 - Who is responsible for routine patient safety measures, such as deep venous thrombosis prophylaxis? … Because of the risk of central nervous system bleeding, anticoagulant use is a shared responsibility—hospitalists … always contact neurosurgery physicians before starting antiplatelet or anticoagulant agents.

  4. Spotlight Case [MONTH] 2003 (ppt file)

    psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.68_slideshow.ppt
    July 01, 2004 - Referenced 4 PROWESS Exclusion Drotrecogin alfa has anticoagulant properties, so patients at high … beta-blockers for coronary artery disease ACE inhibitors for congestive heart failure Pharmacologic prophylaxis

  5. Microsoft Word - Johns_Hopkins_Case_Study.docx (pdf file)

    qualityindicators.ahrq.gov/Downloads/Resources/Case_Studies/Johns_Hopkins_Case_Study.pdf
    August 01, 2019 - focuses on the identification of risk factors for VTE and ensuring that patients receive the appropriate prophylaxis … The Collaborative identified service-specific champions, and investigated strategies to improve VTE prophylaxis … The tool requires patient risk stratification and generates an algorithm for administration of prophylaxis … Current improvement efforts include compliance with ordering and administration of appropriate prophylaxis

  6. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - 2 A variety of strategies to prevent VTE are available, including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis, within and between classes of VTE prophylaxis modalities, and … duration of VTE prophylaxis in patients undergoing these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE prophylaxis versus no VTE prophylaxis did not provide strong evidence … low SoE data on the comparative effectiveness of aspirin or mechanical devices with LMWH or other anticoagulants

  7. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - 2 A variety of strategies to prevent VTE are available, including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis, within and between classes of VTE prophylaxis modalities, and … duration of VTE prophylaxis in patients undergoing these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE prophylaxis versus no VTE prophylaxis did not provide strong evidence … low SoE data on the comparative effectiveness of aspirin or mechanical devices with LMWH or other anticoagulants

  8. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - 2 A variety of strategies to prevent VTE are available, including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis, within and between classes of VTE prophylaxis modalities, and … duration of VTE prophylaxis in patients undergoing these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE prophylaxis versus no VTE prophylaxis did not provide strong evidence … low SoE data on the comparative effectiveness of aspirin or mechanical devices with LMWH or other anticoagulants

  9. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
    June 01, 2017 - 2 A variety of strategies to prevent VTE are available, including pharmacological (antiplatelet, anticoagulant … strategies with no VTE prophylaxis, within and between classes of VTE prophylaxis modalities, and … duration of VTE prophylaxis in patients undergoing these surgeries; and the efficacy of VTE prophylaxis … Comparisons of mechanical VTE prophylaxis versus no VTE prophylaxis did not provide strong evidence … low SoE data on the comparative effectiveness of aspirin or mechanical devices with LMWH or other anticoagulants

  10. Systematic Review Update of Venous Thromboembolism Prophylaxis in Orthopedic Surgery | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/thromboembolism-update/research-protocol/

  11. PowerPoint Presentation (ppt file)

    psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.14_slideshow.ppt
    May 01, 2003 - Preventing Catheter-Related Thrombosis Low molecular weight heparin No clinical trials for prophylaxis

  12. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    ce.effectivehealthcare.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.

  13. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    www.cpsi.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.

  14. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    www.cahps.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.

  15. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    talkingquality.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.

  16. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    patientregistry.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.

  17. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    ahrqpubs.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.

  18. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    monahrq.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.

  19. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    healthcare411.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.

  20. Auditing Your Briefings and Debriefings Process: Slide Presentation | Agency for Healthcare Research and Quality

    cahps.ahrq.gov/hai/tools/surgery/modules/implementation/audit-briefing-slides.html
    December 01, 2017 - Bleeding concerns (e.g., anticoagulant use). Blood availability. Allergies. … Deep vein thrombosis prophylaxis. Warmers. Lab/radiology review. … Deep vein thrombosis (DVT) prophylaxis  - 100% Yes. Glycemic control - 40% Yes. … Anticoagulant use - 10% Yes. Access issues - 20% Yes. Airway risk - 20% Yes.
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

www.ahrq.gov (106)

psnet.ahrq.gov (62)

cmext.ahrq.gov (60)

effectivehealthcare-admin.ahrq.gov (59)

ce.effectivehealthcare.ahrq.gov (53)

effectivehealthcare.ahrq.gov (46)

www.uspreventiveservicestaskforce.org (20)

www.qualitymeasures.ahrq.gov (17)

digital.ahrq.gov (10)

pbrn.ahrq.gov (8)

pcmh.ahrq.gov (8)

www.cpsi.ahrq.gov (8)

ahrqpubs.ahrq.gov (7)

cahps.ahrq.gov (7)

healthcare411.ahrq.gov (7)

monahrq.ahrq.gov (7)

patientregistry.ahrq.gov (7)

qualityindicators.ahrq.gov (6)

talkingquality.ahrq.gov (6)

www.cahps.ahrq.gov (6)

preventiveservices.ahrq.gov (5)

teamstepps.ahrq.gov (5)

www.healthcare411.ahrq.gov (5)

www.innovations.ahrq.gov (5)

www.monahrq.ahrq.gov (5)

www.talkingquality.ahrq.gov (5)

cds.ahrq.gov (3)